Skip to main content

Table 1 Baseline characteristics of the RA patients.

From: Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study

  RA Patients
General Characteristics
 Age (years) 54 ± 15
 Sex female N (%) 15 (65)
 Height (cm) 165 ± 8
 BMI (kg/m2) 30 ± 6
Disease-related Characteristics
 RF Positive N (%) 20 (87)
 Disease duration (years) 11 ± 11
CVD Risk Factors
 Family history of CVD 12 (40)
 Diabetes 1 (3)
 Hypertension 6 (20)
 High Cholesterol 6 (20)
 Insulin Resistance 10 (33)
 Overweight 7 (23)
 Obese 13 (43)
Smoking Status
 Never smoked 11 (48.8)
 Previous smokers 7 (30)
 Current smokers 5 (22)
Rheumatologic Medications
 Methotrexate (%) 16 (70)
 Glucocorticosteroids (%) 6 (26)
 Medium dose GC (≥7.5 mg) (%) 13 (56)
 NSAIDs (%) 6 (26)
Cardiovascular Medications
 Anti-hypertensive treatment (%) 5 (22)
 Anti-hypercholesterolemic (%) 4 (17)
  1. Results are expressed as Number (%) and mean ± standard deviation. Diabetes = fasting glucose >7 mmol/l and/or oral hypoglycaemic medication or insulin use; hypertension = SBP >140 mmHg, DBP >90 mmHg or use of anti-hypertensive’s; high cholesterol = fasting cholesterol >4.1 mmol/l or use of anti-hypercholesterolemics; insulin resistance = homeostasis model assessment ≥2.5 or quantitative insulin sensitivity check index ≤0.333; overweight: BMI ≥ 23-27.9; obese: BMI ≥ 28. BMI: body mass index, RF: rheumatoid factor.